Life sciences organizations face the challenge of converting great discoveries and research breakthroughs into public acceptance and market success. For companies specializing in pharmaceuticals, biotechnology, medical products and technology and medical devices, the life sciences are changing at a remarkable rate. Even an improved global economic climate is unlikely to halt efforts by the developed world’s governments to contain spending on drugs. Emerging markets will follow their lead and pursue further spending control measures. Regulatory requirements—particularly the linkage among the benefits, risks, and cost of products—will increase, while the industry pipeline shows little sign of delivering sufficient innovation to compensate for such pressures.

We at Atkinson Stuart understand the intricacies and challenges of this sector. Our Life Science Practice supports management and boards of directors providing search consulting services to emerging players (early-stage, venture capital-backed biotech-firms) to established fully integrated global pharmaceutical manufacturers and marketers. We help to find people with the right leadership skills who are able to successfully anticipate technological, economic and regulatory developments and rapidly seize the commercial opportunities that arise to enhance the company’s competitive advantage. We fill senior and midlevel position in sales, corporate finance, merger & acquisitions, regulatory affairs, legal, human resources, IT and a range of other corporate functions.